Glycine alleviated oxidative stress injury via upregulating caveolin-3/endothelial nitric oxide synthase signal in the myocardium of diabetic rats
陈丽丽,张元,苏娃婷,雷少青,夏中元
DOI: https://doi.org/10.3760/cma.j.cn115791-20190916-00339
2020-01-01
Abstract:Objective:To explore the effects of glycine on myocardial caveolin-3/endothelial nitric oxide synthase (eNOS) signal and oxidative stress in diabetic myocardium of rats.Methods:According to random number table method, 30 adult male SD rats at 8 weeks of age were randomly divided into 3 groups (10 in each group): the control group (C), diabetes mellitus group (D, diabetes model induced by single intraperitoneal streptozotocin injection), diabetes+glycine treatment group (D+Gly, after the success of the diabetes model, treated by 1% glycine aqueous solution instead of drinking water treatment for 8 weeks). The H9C2 cells were exposed to 30 mmol/L glucose and 140 μmol/L glycine context and cultured for 48 hours. The contents of super oxide dismutase (SOD), malondialdehyde (MDA), lactate dehydrogenase (LDH) and total protein and CCK-8 test were detected using commercial assay kits. HE staining was used to detect the pathological changes of diabetic myocardium, and the expression of caveolin-3 and p-eNOS were detected by Western blot. One-way analysis of variance was used for comparison between groups, and Tukey test was used for pairwise comparison.Results:(1) The MDA content of myocardial tissue were significantly higher in rats of diabetes group than that in control group (
q=6.57,
P<0.05). The SOD content of myocardial tissue and the expression levels of caveolin-3 and p-eNOS were significantly lower in rats of diabetes group than that in control group (
q=15.72, 11.84,
15.18, all
P<0.05). (2) The MDA content of myocardial tissue were significantly lower in diabetic rats treated with glycine than that in untreated diabetic rats [(4.81±0.94) vs (6.06±0.85) nmol/mg prot,
q=4.51,
P<0.05]. The SOD content of myocardial tissue and the expression of caveolin-3 and p-eNOS were significantly higher in diabetic rats treated with glycine than that in untreated diabetic rats [(73.17±11.83) vs (42.01±10.35) U/mg prot, 0.78±0.08 vs 0.55±0.14, 0.83±0.13 vs 0.50±0.12,
q=9.17,
6.05,
10.02, all
P<0.05]. (3) The SOD content, caveolin-3 and p-eNOS expression were significantly decrease in H9C2 cardiomyocytes in high glucose group than that in low glucose group (
q=10.04,
10.20,
18.25, all
P<0.05), while the MDA content was significantly higher than low glucose group (
q=18.98,
P<0.05). (4) The SOD content, caveolin-3, p-eNOS protein expression were significantly higher in high glucose-exposed H9C2 cardiomyocytes with versus without glycine treatment [(11.35±1.64) vs (7.61±1.02) U/mg prot, 0.91±0.06 vs 0.77±0.05, 0.74±0.04 vs 0.62±0.06,
q=4.21, 6.21,
5.77, all
P<0.05], while MDA content was significantly lower than untreated group [(1.42±0.08) vs (2.07±0.15) nmol/mg prot,
q=10.82,
P<0.05].
Conclusion:Glycine exerted diabetic myocardial protection may through regulating caveolin-3/eNOS signal and alleviating oxidative stress injury.